| VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
|---|---|---|---|---|---|---|---|---|
| TVIS10016040 | HBV | ENSG00000165995.24 | protein_coding | CACNB2 | No | No | 783 | Q08289 |
| TVIS10012545 | HBV | ENSG00000165995.24 | protein_coding | CACNB2 | No | No | 783 | Q08289 |
| TVIS10011001 | HBV | ENSG00000165995.24 | protein_coding | CACNB2 | No | No | 783 | Q08289 |
| TVIS10012546 | HBV | ENSG00000165995.24 | protein_coding | CACNB2 | No | No | 783 | Q08289 |
| TVIS10007207 | HBV | ENSG00000165995.24 | protein_coding | CACNB2 | No | No | 783 | Q08289 |
| TVIS10026202 | HBV | ENSG00000165995.24 | protein_coding | CACNB2 | No | No | 783 | Q08289 |
| TVIS10034297 | HBV | ENSG00000165995.24 | protein_coding | CACNB2 | No | No | 783 | Q08289 |
| TVIS10020768 | HBV | ENSG00000165995.24 | protein_coding | CACNB2 | No | No | 783 | Q08289 |
| TVIS10020855 | HBV | ENSG00000165995.24 | protein_coding | CACNB2 | No | No | 783 | Q08289 |
| TVIS10047896 | HBV | ENSG00000165995.24 | protein_coding | CACNB2 | No | No | 783 | Q08289 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
| Gene | CACNB2 |
|---|---|
| DrugBank ID | DB01388 |
| Drug Name | Mibefradil |
| Target ID | BE0002354 |
| UniProt ID | Q08289 |
| Regulation Type | inhibitor |
| PubMed IDs | 16899990; 10372226; 10665814 |
| Citations | Lee TS, Kaku T, Takebayashi S, Uchino T, Miyamoto S, Hadama T, Perez-Reyes E, Ono K: Actions of mibefradil, efonidipine and nifedipine block of recombinant T- and L-type Ca channels with distinct inhibitory mechanisms. Pharmacology. 2006;78(1):11-20. Epub 2006 Aug 7.@@Mocanu MM, Gadgil S, Yellon DM, Baxter GF: Mibefradil, a T-type and L-type calcium channel blocker, limits infarct size through a glibenclamide-sensitive mechanism. Cardiovasc Drugs Ther. 1999 Apr;13(2):115-22.@@Jimenez C, Bourinet E, Leuranguer V, Richard S, Snutch TP, Nargeot J: Determinants of voltage-dependent inactivation affect Mibefradil block of calcium channels. Neuropharmacology. 2000;39(1):1-10. |
| Groups | Investigational; Withdrawn |
| Direct Classification | Tetralins |
| SMILES | COCC(=O)O[C@]1(CCN(C)CCCC2=NC3=CC=CC=C3N2)CCC2=C(C=CC(F)=C2)[C@@H]1C(C)C |
| Pathways | |
| PharmGKB | PA450492 |
| ChEMBL | CHEMBL45816 |
